Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction | HTML
Noribogaine is a G-protein biased κ-opioid receptor agonist - ScienceDirect
Buprenorphine: A Promising Yet Overlooked Tool
Untangling the complexity of opioid receptor function | Neuropsychopharmacology
Buprenorphine - an attractive opioid with underutilized potentia | JPR
Understanding opioids in veterinary medicine
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Opioid Agonists & Antagonists | Basicmedical Key
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
κ-opioid receptor - Wikipedia
Opioid Receptor | kappa, mu Opioid Receptor
PDF] The Roles of Opioid Receptors and Agonists in Health and Disease Conditions | Semantic Scholar
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Application of Receptor Theory to the Design and Use of Fixed-Proportion Mu-Opioid Agonist and Antagonist Mixtures in Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
Differential Opioid Agonist Regulation of the Mouse μ Opioid Receptor* - Journal of Biological Chemistry
Opioid Receptors - Pharmacology
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids | PLOS ONE